MARKET

NTBL

NTBL

Notable Labs
NASDAQ
0.8210
+0.0210
+2.63%
Opening 12:48 05/28 EDT
OPEN
0.7780
PREV CLOSE
0.8000
HIGH
0.8600
LOW
0.7780
VOLUME
59.52K
TURNOVER
0
52 WEEK HIGH
11.20
52 WEEK LOW
0.7150
MARKET CAP
7.40M
P/E (TTM)
-0.3552
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at NTBL last week (0520-0524)?
Weekly Report · 1d ago
Bears are Losing Control Over Notable Labs (NTBL), Here's Why It's a 'Buy' Now
NASDAQ · 4d ago
Weekly Report: what happened at NTBL last week (0513-0517)?
Weekly Report · 05/20 10:24
Novavax, Capricor Therapeutics, Arcutis Biotherapeutics among healthcare movers
Healthcare On the Move: Novavax, Capricor Therapeutics, Arcutis Biotherapeutics among healthcare movers. S&P 500 Health Care Sector contributes 58% of index to Pharmaceuticals, Biotechnology & Life Science sector. S&p 500 Health care sector includes equipment and services.
Seeking Alpha · 05/17 14:00
Notable Labs Is Maintained at Buy by Chardan Capital
Dow Jones · 05/16 16:18
Notable Labs Price Target Cut to $5.00/Share From $7.00 by Chardan Capital
Dow Jones · 05/16 16:18
Chardan Capital Maintains Buy on Notable Labs, Lowers Price Target to $5
Benzinga · 05/16 16:08
NTBL Stock Earnings: Notable Labs Misses EPS for Q1 2024
Notable Labs reported earnings per share of -42 cents for the first quarter of 2024. The company reported revenue of $1,000. This was below the analyst estimate for EPS of -39 cents. Notable Labs also reported results for the fourth quarter of 2015.
Investorplace · 05/16 15:53
More
About NTBL
Notable Labs Ltd, formerly Vascular Biogenics Ltd, is an Israel-based clinical-stage biopharmaceutical company committed to developing next-generation, targeted medicines for difficult-to-treat medical conditions. The Company has created a pipeline of therapeutics that address cancer and immune-inflammatory diseases with the goal of significantly improving patient outcomes and overcoming the limitations of approved treatments. The Company's product candidates are built off of two platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels, and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications.

Webull offers Notable Labs Ltd stock information, including NASDAQ: NTBL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NTBL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NTBL stock methods without spending real money on the virtual paper trading platform.